Results 41 to 50 of about 60,311 (178)

Middle East respiratory syndrome coronavirus—a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins

open access: yesInternational Journal of Infectious Diseases, 2023
Objectives: The World Health Organization priority zoonotic pathogen Middle East respiratory syndrome (MERS) coronavirus (CoV) has a high case fatality rate in humans and circulates in camels worldwide.
Esam I. Azhar   +7 more
doaj   +1 more source

Replication of MERS and SARS coronaviruses in bat cells offers insights to their ancestral origins

open access: yesEmerging Microbes and Infections, 2018
Previous findings of Middle East Respiratory Syndrome coronavirus (MERS-CoV)-related viruses in bats, and the ability of Tylonycteris-BatCoV HKU4 spike protein to utilize MERS-CoV receptor, human dipeptidyl peptidase 4 hDPP4, suggest a bat ancestral ...
Susanna K. P. Lau   +13 more
doaj   +1 more source

Unraveling the drivers of MERS-CoV transmission [PDF]

open access: yesProceedings of the National Academy of Sciences, 2016
Significance Since it was discovered in 2012, Middle East respiratory syndrome coronavirus (MERS-CoV) has infected more than 1,700 persons, one-third of whom died, essentially in the Middle East. Persons can get infected by direct or indirect contact with dromedary camels, and although human-to-human transmission is not self ...
Simon Cauchemez   +24 more
openaire   +4 more sources

Virtual Screening and Inhibition of Middle East Respiratory Syndrome Coronavirus Replication by Targeting Papain-like Protease

open access: yesDr. Sulaiman Al Habib Medical Journal, 2021
Infection by the emerging, potentially zoonotic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) presents a severe health hazard to humans and is often fatal.
Mahmoud Kandeel   +6 more
doaj   +1 more source

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

open access: yesViruses, 2018
Middle East respiratory syndrome coronavirus (MERS-CoV), a novel infectious agent causing severe respiratory disease and death in humans, was first described in 2012.
Svenja Veit   +4 more
doaj   +1 more source

Scanning Electron Microscopic Findings on Respiratory Organs of Some Naturally Infected Dromedary Camels with the Lineage-B of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Saudi Arabia—2018

open access: yesPathogens, 2021
The currently known animal reservoir for MERS-CoV is the dromedary camel. The clinical pattern of the MERS-CoV field infection in dromedary camels is not yet fully studied well.
Abdelmohsen Alnaeem   +8 more
doaj   +1 more source

[Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – Camel virus and zoonotic pathogen]

open access: yesBerliner und Münchener Tierärztliche Wochenschrift, 2021
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been firstly identified in September 2012 as causative agent of severe and lethal respiratory disease in humans (Table 1).
Christian Meyer zu Natrup, Asisa Volz
doaj   +1 more source

Evaluating MERS-CoV Entry Pathways [PDF]

open access: yes, 2019
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic pathogen with a broad host range. The extent of MERS-CoV in nature can be traced to its adaptable cell entry steps. The virus can bind host-cell carbohydrates as well as proteinaceous receptors.
Qing, Enya   +3 more
openaire   +2 more sources

Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels

open access: yesOne Health, 2018
Thus far, no human MERS-CoV infections have been reported from Israel. Evidence for the circulation of MERS-CoV in dromedaries has been reported from almost all the countries of the Middle East, except Israel.
Dan David   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy